Abstract:Primary aldosteronism (PA) is a common cause of secondary hypertension with a prevalence rate of approximately 5% to 10%. The characteristics of PA include excessive aldosterone secretion and inhibition of the renin-angiotensin system. Aldosterone-producing adenoma (APA) is a common subtype of PA, accounting for about 40% to 50% of PA cases. [ 1 ] Compared with essential hypertension, the incidence of stroke and myocardial infarction in PA patients is significantly higher, so early diagnosis and active treatment are crucial. [ 2 ] Obstructive sleep apnea (OSA) is a common sleep-related disorder. In recent years, with the rise in overweight and obese individuals, along with population aging, the occurrence of OSA has been escalating, becoming a pressing public health concern. [ 3 ] OSA poses a significant threat to life safety and may result in accidental deaths and sudden fatalities during sleep. [ 4 ] Furthermore, it exhibits a strong correlation with metabolic dysregulation, cardiovascular and nervous system impairments, as well as memory decline and cancer development. [ 5 ] Multiple studies reveal a close link between OSA and PA. A cross-center, multi-ethnic study found that 67.6% of PA patients had OSA, with a significant correlation between plasma aldosterone and OSA severity. [ 6 ] Nakamura et al discovered that 55% (39 of 71) of Japanese PA patients had OSA. [ 7 ] Therefore, conducting OSA examinations and implementing management strategies for PA patients is imperative. A meta-analysis revealed that OSA affects nearly 46% of 2335 PA patients (95% CI = 39–54%). Notably, hypertensive patients with PA have a significantly higher OSA prevalence compared to those without PA (OR = 2.01, 95% CI = 1.37–2.95, P < .001). In addition, the study demonstrated that approximately 27% of 3498 OSA patients also had PA (95% CI = 24–29%). Notably, the prevalence of PA was significantly higher in OSA patients compared to non-OSA patients (OR = 2.03, 95% CI = 1.30–3.16, P = .002). [ 8 ] Di Murro et al reported that approximately 34% of hypertensive patients with OSA also have PA. [ 9 ] Increasing research indicates that there is a complex interaction between OSA and PA, and they are likely to share some pathological mechanisms. [ 10 , 11 ] Despite numerous studies exploring the pathophysiological links between PA and OSA, the search for common genetic factors remains inadequate.

Associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea—what do we know so far?

Primary aldosteronism and obstructive sleep apnea: What do we know thus far?

Exploring the pathogenesis linking primary aldosteronism and obstructive sleep apnea via bioinformatic analysis

Primary Aldosteronism and Sleep Apnea Syndrome

The Prevalence of Obstructive Sleep Apnea in Patients With Primary Aldosteronism

PREVALENCE AND CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM IN PATIENTS WITH HYPERTENSION COMORBID WITH OBSTRUCTIVE SLEEP APNEA

Stroke Risks in Primary Aldosteronism with Different Treatments: A Systematic Review and Meta-Analysis

Primary Aldosteronism and Obstructive Sleep Apnea: A Meta-Analysis of Prevalence and Metabolic Characteristics

Elevated renin activity and change in sleep apnea with primary aldosteronism

[BP.05.01] THE CLINICAL CHARACTERISTICS OF PATIENTS WITH PRIMARY ALDOSTERONISM COMPLICATED WITH OBSTRUCTIVE SLEEP APNEA - HYPOPNEA SYNDROME

Clinical Characteristics of Snoring Patients with Primary Aldosteronism and Obstructive Sleep Apnea–hypopnea Syndrome

Clinical Characteristics of Obstructive Sleep Apnea and Comorbid Primary Aldosteronism

Primary aldosteronism and obstructive sleep apnea: the strong ties between them

What We Know about and What Is New in Primary Aldosteronism

The Study of Screening Rates of Primary Aldosteronism in Obstructive Sleep Apnea Syndrome with Hypertension As the Blood Pressure Classification

[Clinical Characteristics of Aldosterone Producing Adenoma and Idiopathic Hyperaldosteronism with Obstructive Sleep Apnea Hypopnea Syndrome].

Primary hyperaldosteronism is associated with increased mortality and morbidity in patients with hypertension and diabetes

Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism

Recent progress in unraveling cardiovascular complications associated with primary aldosteronism: a succinct review

Primary Aldosteronism More Prevalent in Patients With Cardioembolic Stroke and Atrial Fibrillation

Primary Aldosteronism and Bone Metabolism: A Systematic Review and Meta-Analysis